India’s patent authorities have dealt a blow to German pharma company Bayer by refusing to overturn an order forcing the company to license one of its patented drugs.
If you have already subscribed please login.
If you have any technical issues please email tech support.
natco, bayer ag, nexavar, IPAB, indian patent controller
